Valor Estate (533160) Q4 22/23 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 22/23 earnings summary
27 Oct, 2026Executive summary
FY23 consolidated revenue rose to Rs 69,823.96 lacs from Rs 21,943.42 lacs; consolidated net loss was Rs 9,000.64 lacs versus profit of Rs 2,178.14 lacs in FY22.
Capital raising, lender settlements and proposed asset monetisations supported a deleveraging plan; management targeted becoming debt-free in FY24.
Financial highlights
Consolidated total income was Rs 80,725.32 lacs versus Rs 26,650.85 lacs; total expenses were Rs 147,098.70 lacs versus Rs 58,059.43 lacs.
Consolidated loss before tax was Rs 6,053.32 lacs, including a one-time Rs 57,500 lacs gain from a lender settlement; FY22 PBT was profit of Rs 14,249.71 lacs.
Consolidated EPS was (Rs 2.94) versus Rs 1.11; consolidated operating cash flow was positive at Rs 9,633.79 lacs versus an outflow of Rs 26,661.87 lacs.
Standalone revenue from operations was Rs 358.04 lacs versus Rs 385.48 lacs; PAT was Rs 3,517.11 lacs versus a loss of Rs 7,514.34 lacs, including exceptional items in FY22.
Outlook and guidance
Management targeted a debt-free balance sheet in FY24 through equity raising and asset monetisation, while maintaining low leverage and pursuing joint ventures and joint development agreements.
Residential demand was expected to remain robust in FY24; launches through branded developers and proposed JV/JDA projects were expected to support future sales momentum and revenue.
Ten BKC was scheduled for possession in June 2024; DB Ozone’s MahaRERA completion timeline was extended to December 2024.
Latest events from Valor Estate
- Q2 consolidated profit reached Rs. 837.92 lakh amid acquisitions and legal uncertainties.533160
Q2 26/27 - Revenue contracted, losses deepened and liquidity risks overshadowed JV-led recovery plans.533160
Q4 19/20 - Warrant-funded recovery and project restarts, constrained by liquidity risks and audit qualifications.533160
Q4 21/22 - Project delays and debt stress weighed on results; recovery hinges on partnerships and liquidity actions.533160
Q4 20/21 - Revenue fell, leverage rose, and major audit and legal uncertainties persisted despite project progress.533160
Q4 14/15 - Revenue fell 18%, losses returned, and project execution advanced amid significant financing and legal risks.533160
Q4 15/16 - Project progress continued amid a wider consolidated loss and material financing and audit risks.533160
Q4 16/17 - Asset sales and equity funding drove a profit rebound and balance-sheet reset.533160
Q4 23/24 - Revenue surged, but losses, liquidity strain and audit qualifications remained significant.533160
Q4 18/19